BPC 157 Banned: Key Facts on the Latest FDA Decision Injectable Peptides: Out of the Back Alley and Into the Light? Berkley Lifesciences Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York RFK Jr. & claimed regenerative peptides like BPC 157 The Niche